This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Octohydroaminoacridine Succinate

Changchun Huayang High-tech Co., Ltd

Drug Names(s): Octohydroaminoacridine Succinate

Description: Octohydroaminoacridine Succinate is a tablet formulation compound structurally designed from tacrine (9-amino-1,2,3,4-octohydroaminoacridine), a reversible acetylcholinesterase inhibitor.

Tacrine is a cholinesterase inhibitor. Cholinesterase inhibitors inhibit the action of acetylcholinesterase, the enzyme responsible for the destruction of acetylcholine. Reduced levels of acetylcholine in the brain are believed to be responsible for some of the symptoms of Alzheimer's disease. By blocking the enzyme that destroys acetylcholine, tacrine increases the concentration of acetylcholine in the brain.

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug